Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Adagene Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 15 | 11 | −4 |
| Shares | 7.53M | 5.94M | −1.59M (−21.1%) |
| Value | $15.4M | $7.60M | −$7.82M (−50.7%) |
New holders (0)
Institutions that held Adagene Inc. at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (4)
Institutions that held Adagene Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Matthews International Capital Management LLC | 364,955 | $734.0K |
| Tudor Investment Corp Et Al | 24,695 | $51.0K |
| Virtu Financial LLC | 19,676 | $40.0K |
| Tower Research Capital LLC (TRC) | 3,627 | $7.00K |